I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Murlentamab, a Low Fucosylated Anti-Müllerian Hormone Type ..:
Prat, Mélissa
;
Salon, Marie
;
Allain, Thibault
...
info:eu-repo/semantics/altIdentifier/doi/10.3390/cancers13081845. , 2021
Link:
https://inserm.hal.science/inserm-03215770
RT Journal T1
Murlentamab, a Low Fucosylated Anti-Müllerian Hormone Type II Receptor (AMHRII) Antibody, Exhibits Anti-Tumor Activity through Tumor-Associated Macrophage Reprogrammation and T Cell Activation
UL https://suche.suub.uni-bremen.de/peid=base-ftuniparissaclay:oai:HAL:inserm-03215770v1&Exemplar=1&LAN=DE A1 Prat, Mélissa A1 Salon, Marie A1 Allain, Thibault A1 Dubreuil, Olivier A1 Noël, Grégory A1 Preisser, Laurence A1 Jean, Bérangère A1 Cassard, Lydie A1 Lemée, Fanny A1 Tabah-Fish, Isabelle A1 Pipy, Bernard A1 Jeannin, Pascale A1 Prost, Jean-François A1 Barret, Jean-Marc A1 Coste, Agnès PB HAL CCSD; MDPI YR 2021 K1 adaptive immunity K1 glyco-engineered antibody K1 immunotherapy K1 murlentamab K1 ovarian cancer K1 tumor-associated macrophages K1 [SDV.CAN]Life Sciences [q-bio]/Cancer JF info:eu-repo/semantics/altIdentifier/doi/10.3390/cancers13081845 LK http://dx.doi.org/https://inserm.hal.science/inserm-03215770 DO https://inserm.hal.science/inserm-03215770 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)